The cash purchase of Sybenetix for an undisclosed sum is the first since Adena Friedman took over as Nasdaq chief in January, providing a glimpse at her likely focus. “Getting into more advanced technologies . . . is a key part of a our strategy,” Ms Friedman told the Financial Times. “The regtech [regulation technology] part of our market technology business will continue to expand.” Nasdaq has diversified beyond its traditional exchanges business as the profitability of equity trading has shrunk over the past decade with regulatory change and heightened competition.

https://www.ft.com/content/6dad3956-7092-11e7-93ff-99f383b09ff9